Search research articles
Contact Us
Filters
Showing results (111-120 of 210) with videos related to
Page
of 21
Sort By:
Blood
|
December 3, 2003
Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis
Mignon L Loh, Shashaank Vattikuti, Suzanne Schubbert, et al.
The New England Journal of Medicine
|
June 30, 2016
Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis
Jason Gotlib, Hanneke C Kluin-Nelemans, Tracy I George, et al.
Haematologica
|
May 11, 2023
Safety and efficacy of zinpentraxin alfa as monotherapy or in combination with ruxolitinib in myelofibrosis: stage I of a phase II trial
Srdan Verstovsek, Lynda Foltz, Vikas Gupta, et al.
British Journal of Haematology
|
June 1, 2021
Clinical and histopathological features of myeloid neoplasms with concurrent Janus kinase 2 (JAK2) V617F and KIT proto-oncogene, receptor tyrosine kinase (KIT) D816V mutations
Nicole Naumann, Johannes Lübke, William Shomali, et al.
The Journal of Allergy and Clinical Immunology
|
March 31, 2012
Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes
Peter Valent, Amy D Klion, Hans-Peter Horny, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 25, 2009
Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generation
Annelie E Abrahamsson, Ifat Geron, Jason Gotlib, et al.
The New England Journal of Medicine
|
February 21, 2024
Rusfertide, a Hepcidin Mimetic, for Control of Erythrocytosis in Polycythemia Vera
Marina Kremyanskaya, Andrew T Kuykendall, Naveen Pemmaraju, et al.
Blood Advances
|
May 31, 2024
Safety and efficacy of luspatercept for the treatment of anemia in patients with myelofibrosis
Aaron T Gerds, Claire Harrison, Jean-Jacques Kiladjian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 21, 2013
Effect of ruxolitinib therapy on myelofibrosis-related symptoms and other patient-reported outcomes in COMFORT-I: a randomized, double-blind, placebo-controlled trial
Ruben A Mesa, Jason Gotlib, Vikas Gupta, et al.
Blood
|
January 18, 2013
International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) & European Competence Network on Mastocytosis (ECNM) consensus response criteria in advanced systemic mastocytosis
Jason Gotlib, Animesh Pardanani, Cem Akin, et al.
Page
of 21
Search research articles
Search
Showing results (111-120 of 210) with videos related to
Sort By:
Page
of 21
Blood
|
December 3, 2003
Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis
Mignon L Loh, Shashaank Vattikuti, Suzanne Schubbert, et al.
The New England Journal of Medicine
|
June 30, 2016
Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis
Jason Gotlib, Hanneke C Kluin-Nelemans, Tracy I George, et al.
Haematologica
|
May 11, 2023
Safety and efficacy of zinpentraxin alfa as monotherapy or in combination with ruxolitinib in myelofibrosis: stage I of a phase II trial
Srdan Verstovsek, Lynda Foltz, Vikas Gupta, et al.
British Journal of Haematology
|
June 1, 2021
Clinical and histopathological features of myeloid neoplasms with concurrent Janus kinase 2 (JAK2) V617F and KIT proto-oncogene, receptor tyrosine kinase (KIT) D816V mutations
Nicole Naumann, Johannes Lübke, William Shomali, et al.
The Journal of Allergy and Clinical Immunology
|
March 31, 2012
Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes
Peter Valent, Amy D Klion, Hans-Peter Horny, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 25, 2009
Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generation
Annelie E Abrahamsson, Ifat Geron, Jason Gotlib, et al.
The New England Journal of Medicine
|
February 21, 2024
Rusfertide, a Hepcidin Mimetic, for Control of Erythrocytosis in Polycythemia Vera
Marina Kremyanskaya, Andrew T Kuykendall, Naveen Pemmaraju, et al.
Blood Advances
|
May 31, 2024
Safety and efficacy of luspatercept for the treatment of anemia in patients with myelofibrosis
Aaron T Gerds, Claire Harrison, Jean-Jacques Kiladjian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 21, 2013
Effect of ruxolitinib therapy on myelofibrosis-related symptoms and other patient-reported outcomes in COMFORT-I: a randomized, double-blind, placebo-controlled trial
Ruben A Mesa, Jason Gotlib, Vikas Gupta, et al.
Blood
|
January 18, 2013
International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) & European Competence Network on Mastocytosis (ECNM) consensus response criteria in advanced systemic mastocytosis
Jason Gotlib, Animesh Pardanani, Cem Akin, et al.
Page
of 21